Exact Mass: 298.1082384
Exact Mass Matches: 298.1082384
Found 144 metabolites which its exact mass value is equals to given mass value 298.1082384,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Picein
Picein is a glycoside. Picein is a natural product found in Salix candida, Halocarpus biformis, and other organisms with data available. Picein, isolated from Picrorhiza kurroa, is a naturally occurring antioxidant[1]. Picein, isolated from Picrorhiza kurroa, is a naturally occurring antioxidant[1].
Antibiotic PS 5
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D013845 - Thienamycins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
Astra 1397
C17H18N2OS (298.11397780000004)
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AC - Synthetic antispasmodics, amides with tertiary amines
7-Methylguanosine
7-methylguanosine is an endogenous methylated nucleoside found in human fluids; methylated purine bases are present in higher amounts in tumor-bearing patients compared to healthy controls.DNA hypermethylation is a common finding in malignant cells and has been explored as a therapeutic target for hypomethylating agents. When chemical bonds to DNA, the DNA becomes damaged and proper and complete replication cannot occur to make the normal intended cell. A DNA adduct is an abnormal piece of DNA covalently-bonded to a cancer-causing chemical. This has shown to be the start of a cancerous cell, or carcinogenesis. DNA adducts in scientific experiments are used as bio-markers and as such are themselves measured to reflect quantitatively, for comparison, the amount of cancer in the subject. 7-Methylguanosine is a substrate for purine-nucleoside phosphorylase and Eukaryotic translation initiation factor 4E. (PMID: 3506820, 17044778, 17264127, 16799933) [HMDB] 7-methylguanosine is an endogenous methylated nucleoside found in human fluids; methylated purine bases are present in higher amounts in tumor-bearing patients compared to healthy controls.DNA hypermethylation is a common finding in malignant cells and has been explored as a therapeutic target for hypomethylating agents. When chemical bonds to DNA, the DNA becomes damaged and proper and complete replication cannot occur to make the normal intended cell. A DNA adduct is an abnormal piece of DNA covalently-bonded to a cancer-causing chemical. This has shown to be the start of a cancerous cell, or carcinogenesis. DNA adducts in scientific experiments are used as bio-markers and as such are themselves measured to reflect quantitatively, for comparison, the amount of cancer in the subject. 7-Methylguanosine is a substrate for purine-nucleoside phosphorylase and Eukaryotic translation initiation factor 4E. (PMID:3506820, 17044778, 17264127, 16799933).
2-Phenylethanol glucuronide
2-Phenylethanol glucuronide is a natural human metabolite of 2-phenylethanol generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. [HMDB] 2-Phenylethanol glucuronide is a natural human metabolite of 2-phenylethanol generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys.
LysoPA(8:0/0:0)
LysoPA(8:0/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(8:0/0:0), in particular, consists of one chain of caprylic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.
4-Ethylphenol glucuronide
4-Ethylphenol glucuronide belongs to the class of organic compounds known as phenolic glycosides. These are organic compounds containing a phenolic structure attached to a glycosyl moiety. Some examples of phenolic structures include lignans and flavonoids. Among the sugar units found in natural glycosides are D-glucose, L-fructose, and L rhamnose. 4-Ethylphenol glucuronide is a uremic toxin (PMID: 30087103).
8-Aminoguanosine
(5R,6R)-3-(2-Acetamidoethylsulfanyl)-6-ethyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
Chakanoside I
Chakanoside i is a member of the class of compounds known as alkyl-phenylketones. Alkyl-phenylketones are aromatic compounds containing a ketone substituted by one alkyl group, and a phenyl group. Chakanoside i is soluble (in water) and a very weakly acidic compound (based on its pKa). Chakanoside i can be found in tea, which makes chakanoside i a potential biomarker for the consumption of this food product.
[3R-(3alph,3aalpha,7alpha,7aalpha)]-7-Dimethyl-3,7a-bis(acetyloxy)hexahydro-3a 1,4-isobenzofurandione
[3R-(3alph,3aalpha,7beta,7aalpha)]-7-Dimethyl-3,7a-bis(acetyloxy)hexahydro-3a 1,4-isobenzofurandione
[3S-(3alpha,3abeta,7beta,7abeta)]-7-Dimethyl-3,7a-bis(acetyloxy)hexahydro-3a 1,4-isobenzofurandione
[3S-(3alpha,3abeta,7alpha,7abeta)]-7-dimethyl-3,7a-bis(acetyloxy)hexahydro-3a 1,4-Isobenzofurandione
(5-amino-3-triazolo[1,5-a]quinazolinyl)-(4-morpholinyl)methanone
(+-)-1,1-Binaphthyl-carbonsaeure-8|(+-)-Binaphthyl-(1.1)-carbonsaeure-(8)|1,1-Binaphthyl-8-carbonsaeure|<1,1>Binaphthyl-8-carbonsaeure|Binaphthyl-(1.1)-carbonsaeure-(8)|[1,1]Binaphthyl-carbonsaeure-(8)|[1,1]binaphthyl-carboxylic acid-(8)
(2-Acetyl-phenyl)-beta-D-glucopyranosid|(2-acetyl-phenyl)-beta-D-glucopyranoside|2-beta-D-glucopyranosyloxyacetophenone|2-glucopyranosyloxyacetophenone|acetophenone-2-O-beta-D-glucopyranoside|o-Acetylphenyl-beta-D-glucopyranosid
O1-((S)-1Phenyl-aethyl)-beta-D-glucopyranuronsaeure|O1-((S)-1phenyl-ethyl)-beta-D-glucopyranuronic acid
2,6-dimethylphenol glucuronide|O1-(2,6-dimethyl-phenyl)-beta-D-glucopyranuronic acid|O1-(2,6-Dimethyl-phenyl)-beta-D-glucopyranuronsaeure
(6R)-5beta-(6,7-dihydroxyethyl)-4-(5-hydroxymethyl-furan-2-yl-methylene)-2beta-ethoxy-dihydrofuran-3-one|pollenfuran B
(2R)-hydroxy-norneomajucin|11-nor-(2R)-hydroxyneomajucin
O1-(2,4-dimethyl-phenyl)-beta-D-glucopyranuronic acid|O1-(2,4-Dimethyl-phenyl)-beta-D-glucopyranuronsaeure
O1-(3,5-dimethyl-phenyl)-beta-D-glucopyranuronic acid|O1-(3,5-Dimethyl-phenyl)-beta-D-glucopyranuronsaeure
(2R:3S)-2.3-Dihydroxy-2-(4-methoxy-benzyl)-bernsteinsaeure-dimethylester|(2R:3S)-2.3-dihydroxy-2-(4-methoxy-benzyl)-succinic acid dimethyl ester|4-O-methyl-piscidic acid dimethyl ester
O1-(2,3-dimethyl-phenyl)-beta-D-glucopyranuronic acid|O1-(2,3-Dimethyl-phenyl)-beta-D-glucopyranuronsaeure
O1-(3,4-dimethyl-phenyl)-beta-D-glucopyranuronic acid|O1-(3,4-Dimethyl-phenyl)-beta-D-glucopyranuronsaeure
2,5-dimethylphenol glucuronide|O1-(2,5-dimethyl-phenyl)-beta-D-glucopyranuronic acid|O1-(2,5-Dimethyl-phenyl)-beta-D-glucopyranuronsaeure
N-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]amino}(3-methoxyphenyl)carboxamide
relative retention time with respect to 9-anthracene Carboxylic Acid is 0.393 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.395
7-Methylguanosine
A positively charged methylguanosine in which a single methyl substituent is located at position 7.
2-tert-Butoxycarbonylamino-4,5,6,7-tetrahydro-benzothiazole-4-carboxylic acid
Ivachtin
A - Alimentary tract and metabolism > A05 - Bile and liver therapy > A05B - Liver therapy, lipotropics > A05BA - Liver therapy D002491 - Central Nervous System Agents > D000427 - Alcohol Deterrents
1,2-BINAPHTHALEN]-4-YLBORONIC ACID
C20H15BO2 (298.11650399999996)
4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pymol[2,3-d]pyrimodin-5-yl)ethyl]benzoic acid
1-butyl-2,3-dimethylimidazol-3-ium,hexafluorophosphate
octane-1,8-diylbis(chlorodimethylsilane)
C12H28Cl2Si2 (298.11065080000003)
3-(4-CHLOROPHENYL)-1-(4-ISOBUTYLPHENYL)PROP-2-EN-1-ONE
s-n-(-)-p-tolylsulfinyltryptamine 97
C17H18N2OS (298.11397780000004)
2-(3-Chloro-5-(methoxymethoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
C14H20BClO4 (298.11431000000005)
3-(3,4-dichlorophenyl)-3,9-diazaspiro[5.5]undecane
3-(2,3-dichlorophenyl)-3,9-diazaspiro[5.5]undecane
3-(4-METHYLPIPERAZIN-1-YL)-4-(METHYLSULFONYL)BENZOIC ACID
4-methyl-1-(4-methyl-3-nitrophenyl)sulfonylpiperidine
Trastuzumab
D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics D004791 - Enzyme Inhibitors
(Z)-2-(2-tert-Butoxycarbonylaminothiazol-4-yl)-2-pentenoic acid
2-AMINO-4,7-DIHYDRO-5H-THIENO[2,3-C]PYRIDINE-3,6-DICARBOXYLICACID3,6-DIETHYLESTER
N-(5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDIN-3-YL)METHANESULFONAMIDE
C12H19BN2O4S (298.11585240000005)
6-tert-butoxycarbonyl-4,5,7,8-tetrahydrothiazolo[4,5-d]azepine-2- carboxylic acid
(10-Phenylanthracen-9-yl)boronic acid
C20H15BO2 (298.11650399999996)
Benzo[1,3]dioxole-5-carboxylic acid Methyl-piperidin-4-yl-aMide hydrochloride
2-(4-ethylpiperazin-1-ylsulfonyl)phenylboronic acid
C12H19BN2O4S (298.11585240000005)
Boronic acid, B-[4-[(4-ethyl-1-piperazinyl)sulfonyl]phenyl]-
C12H19BN2O4S (298.11585240000005)
B-[1,1-Binaphthalen]-4-ylboronic acid
C20H15BO2 (298.11650399999996)
6,11-Dihydro-11-ethyl-6-methyl-9-nitro-5H-pyrido[2,3-B][1,5]benzodiazepin-5-one
2-[[2-(2-methylphenoxy)ethylthio]methyl]-1H-benzimidazole
C17H18N2OS (298.11397780000004)
4-(alpha-L-Rhamnopyranosyloxy)benzoic acid methyl ester
(2S,4R)-4-(hydroxymethyl)-6-(4-nitroanilino)cyclohexane-1,2,3-triol
3-[(Pyrazine-2-carbonyl)-hydrazono]-N-pyridin-2-yl-butyramide
1-(1-azepanyl)-2-[(5-methyl-4-nitro-1H-pyrazol-3-yl)thio]ethanone
2-[[5-[2-(1H-benzimidazol-2-yl)ethyl]-4-methyl-1,2,4-triazol-3-yl]thio]acetonitrile
N-(4-methoxyphenyl)-3,4-dihydro-1H-isoquinoline-2-carbothioamide
C17H18N2OS (298.11397780000004)
N-[3-(1,3-benzodioxol-5-yl)-2-propen-1-ylidene]-5-methyl-1H-pyrazole-3-carbohydrazide
6-(4-Ethylphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid
6-(3-Ethylphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid
Dimethylaminopropionylphenothiazine
C17H18N2OS (298.11397780000004)
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AC - Synthetic antispasmodics, amides with tertiary amines
PS-5
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D013845 - Thienamycins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams